Disclaimer

Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or legal liability for any errors in the text or for the misuse or misapplication of material in this work. Except where otherwise stated, drug dosages and recommendations are for the non-pregnant adult who is not breastfeeding.

Show Summary Details
Page of

Cardiac resynchronization therapy 

Cardiac resynchronization therapy
Chapter:
Cardiac resynchronization therapy
Author(s):

Dr Ricardo Petraco

, Dr Ricardo Petraco

, Dr Larry Mulligan

, and Dr Francisco Leyva

DOI:
10.1093/med/9780199594764.003.0014
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 09 May 2021

The effect of heart failure on survival is comparable to cancer. Despite advances in pharmacological therapy, over half of all patients die within four years of the diagnosis and more than a third die within one year of a first hospitalization. In addition, heart failure has a devastating effect on quality of life, similar to that associated with a stroke, chronic haemodyalisis, and motor neurone disease.

The development of cardiac resynchronization therapy (CRT) over the past decade marks a new era of device therapy for patients with heart failure. Evidence supporting CRT initially emerged from single case studies and small patient series. Subsequently, the findings of large randomized controlled trials have placed CRT firmly within clinical guidelines for the treatment of heart failure. The increasing demand for CRT is testament to the evidence-based practice that characterises modern cardiology.

This is an opportune time to reflect on the history of CRT research. From over 3000 published studies and reviews on the subject, we have selected the ten papers which we feel most adequately represent the evolution of CRT research over the years. Prominent in our approach for this review is the intention to illustrate how research has evolved from exploration of first principles to the emergence of clinically applicable findings from randomized controlled trials.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.